伝統医薬データベース　

サイト内検索結果「」

全16,951件中、3,161件～3,180件を表示しています。
[1] ・・・ [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] ・・・ [848]

Lancemaside A ラット Lancemaside A,Codonolaside II,(4aR,5R,6aS,6bR,10S,12aR)-(2S,3R,4S,5S)-3-(((2S,3R,4S,5R,6S)-3,4-dihydroxy-6-methyl-5-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetra

6322. [生薬成分の代謝] 代謝物『Geniposide』

(1S,4aS,7aS)-methyl 7-(hydroxymethyl)-1-(((2R,3S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate Geniposide 512-63-8 C17H24O

6323. [生薬成分の代謝] 代謝物『Genistein』

5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one Genistein 446-72-0 C15H10O5 270.241 270.0528 271.0607 269.045 Genistein 代謝物

6324. [生薬成分の代謝] 代謝物『(-)-epicatechin 3-O-gallate』

(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl 3,4,5-trihydroxybenzoate (-)-epicatechin 3-O-gallate 128585-96-6 C22H18O10 442.379 442.09 443.0978 441.0822 Epicatechin 3-O-gallate 代謝物

6325. [生薬成分の代謝] 代謝物『Cycasin』

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-((methyldiazenyl)methoxy)tetrahydro-2H-pyran-3,4,5-triol Cycasin 14901-08-7 C8H16N2O6 236.225 236.1008 237.1087 235.093 Cycasin 代謝物

6326. [生薬成分の代謝] 代謝マップ『Sennidin B』

Sennidin B 腸内細菌代謝　ラット腸内細菌フローラ rel-(9S*, 9'R*)-Sennidin B,Rhein anthrone,rel-(9R*, 9'R*)-Sennidin A,Rhein 7105255, 3664804 1) Hattori M., Kim G., Motoike S., Kobashi K. and Namba T.: Metabolism of sen

6327. [生薬成分の代謝] 代謝マップ『6-O-Veratorylcatalpol』

6-O-Veratorylcatalpol ラット (Sprague-Dawley rat) 6-O-Veratryl catalpol 19353737 1) Eun Jeong Park, Sei-Ryang Oh, Hyeong-Kyu Lee and Hye Suk Leea, Liquid chromatography–mass spectrometry for the simulta

6328. [生薬成分の代謝] 代謝物『Ganodermatriol』

2-((4R)-4-((3S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,4,5,6,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentylidene)propane-1,3-diol Ganodermatriol 105300-28-5

6329. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 40 mg/kg 4.08 ± 2.6 h 651.1 ± 164.3 ng∙h∙ml^-1 0-limit 9.61 ± 4.7 h 0.65 ± 0.4 h a p< 0.05, b p< 0.01 compared with conventional rats; Data are expressed as means±S.D

6330. [生薬成分の代謝] 代謝マップ『Cinobufagin』

Cinobufagin 微生物、ラット Cinobufagin,3-Acetyl cinobufagin Intragastric administration 17911017, 17928276 1) Jian Zhang, Yang Sun, Ji-Hua Liu, Bo-Yang Yu, and Qiang Xu, A Microbial transformation of three b

6331. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 40 mg/kg 16.26 ± 4.2 h 2168.1 ± 567.4 ng∙h∙ml^-1 0-limit 18.53 ± 3.2 h 1.93 ± 0.6 h a p< 0.05, b p< 0.01 compared with conventional rats; Data are expressed as means±

6332. [生薬成分の代謝] 代謝物『10-Hydroxyrhyisonchophylline』

(E)-methyl 2-((1'S,6'R,8a'S)-6'-ethyl-5-hydroxy-2-oxo-3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-3,1'-indolizine]-7'-yl)-3-methoxyacrylate 10-Hydroxyrhyisonchophylline C22H28N2O5 400.475 400.199

6333. [生薬成分の代謝] 代謝物『10-Hydroxyrhynchophylline』

(E)-methyl 2-((1'R,6'R,8a'S)-6'-ethyl-5-hydroxy-2-oxo-3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-3,1'-indolizine]-7'-yl)-3-methoxyacrylate 10-Hydroxyrhynchophylline C22H28N2O5 400.475 400.1998 4

6334. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 40 mg/kg 2.61 ± 1.4 h 43.9 ± 8.9 ng∙h∙ml^-1 0-limit 9.56 ± 1.6 h 1.28 ± 0.6 h a p< 0.05, b p< 0.01 compared with conventional rats; Data are expressed as means±S.D. (

6335. [生薬成分の代謝] 代謝パラメータ『Intravenous administration』

Intravenous administration 25 mg/kg 8.72 ± 2.49 mg/ml 2.97 ± 0.24 min^-1 14.0 ± 1.1 min 0.0175 ± 0.0072 mg/ml 0.123 ± 0.028 min^-1 337.5 ± 87.6 min 2.86 ± 0.86 l/kg 5.64 ± 1.82 l/kg 124.07 ± 25.08

6336. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 50 mg/kg 18.0 ± 0.6 min 0.595 ± 0.125 mg/ml 27.76 ± 0.13 mg・min/ml 0-480 Each value represents mean ± S.D. (n=4) Ganoderic Acid A 代謝パラメータ

6337. [生薬成分の代謝] 代謝マップ『6-Shogaol』

6-Shogaol ヒト 6-Shogaol Oral administration,Oral administration,Oral administration 21638149, 21337351, 18708382 1) Yanke Yu, Suzanna Zick, Xiaoqin Li, Peng Zou, Benjamin Wright, and Duxin Sun, Examina

6338. [生薬成分の代謝] 代謝マップ『6-Shogaol』

6-Shogaol ヒト 10-Gingerol Oral administration,Oral administration,Oral administration 21638149, 21337351, 18708382 1) Yanke Yu, Suzanna Zick, Xiaoqin Li, Peng Zou, Benjamin Wright, and Duxin Sun, Exami

6339. [生薬成分の代謝] 代謝物『2-oxo-4-(1-oxobut-3-en-2-yl)-5,6-dihydro-2H-pyran-3-carbaldehyde』

2-oxo-4-(1-oxobut-3-en-2-yl)-5,6-dihydro-2H-pyran-3-carbaldehyde 2-oxo-4-(1-oxobut-3-en-2-yl)-5,6-dihydro-2H-pyran-3-carbaldehyde C10H10O4 194.187 194.0579 195.0657 193.0501 Swertiamarin 代謝物

6340. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 5 mg/kg 18.1 ± 2.5 min 0.037 ± 0.008 mg/ml 3.29 ± 0.98 mg・min/ml 0-480 Each value represents mean ± S.D. (n=4) Ganoderic Acid A 代謝パラメータ

[1] ・・・ [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] ・・・ [848]
全16,951件中、3,161件～3,180件を表示しています。

ページの上へ戻る

TOPICS

生薬

漢方

試験薬物

遺伝子解析情報

化学分析情報

活性試験情報

生薬成分の代謝情報

探索研究